Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction

Pregnancy Clinical Trial

Official title:

Outpatient Foley Catheter Compared to Usual Inpatient Care for Cervical Ripening: a Randomized Controlled Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02546193
• Other study ID #: 14-008988
• Status: Terminated
• Phase: N/A
• Start date: September 2015
• Est. completion date: June 8, 2017

Study information

• Verified date: May 2019
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Induction of labor, or causing labor to start before it otherwise starts spontaneously, is sometimes necessary as pregnancy progresses to ensure the safety of both mother and infant. Labor induction often begins with cervical ripening, in which various methods are used to prepare the cervix for contractions and labor. Cervical ripening is beneficial and decreases the need for cesarean section; however, it can be a lengthy process. By tradition, pregnant women are admitted to the hospital at the start of this process and remain inpatient until after the baby is born.

There is increasing interest in allowing the mother to return to her own home during the very first part of this process. She may be more satisfied in a more comfortable environment with her family. Growing scientific evidence supports use of the Foley catheter as an approach to outpatient cervical ripening. The Foley catheter is a safe, effective method that is already used often in the inpatient setting. It does not cause increased health risks for either mother or baby. Previous research studies have shown that it is just as safe and effective when women return to their own homes with a Foley catheter and that women spend less time in the hospital before delivery. More information is needed before this becomes a standard of care. This research study will allow pregnant women to return home for the first night of their labor induction with a Foley catheter in place. In the morning they will return to the hospital and stay until after delivery. They will be compared to a group of women who remain in the hospital for their entire labor induction. The benefits to going home during labor induction may include increasing maternal satisfaction and optimizing the use of resources in the hospital.

Description:

This study began as a randomized controlled trial, but due to difficulty enrolling and high screen-failure rates, was modified to a prospective study design allowing participants to choose the arm they wished to participate in at the time of providing informed consent. The intervention group (both designs) was comprised of low risk pregnant women who will have a Foley catheter placed followed by dismissal home with return in the morning for continuation of the labor induction process. The control group consists of women (both designs) who will remain inpatient during the entire cervical ripening phase followed by continuation of the labor induction process in the inpatient setting.

Low risk pregnant women at term will be enrolled in clinic after their providers have recommended induction of labor for a specific indication. They will be educated about induction of labor, the Foley catheter, and the proposed research study. If they would like to participate, they will be consented in the clinic. For the RCT design, a computer-generated randomization would occur on the morning of the planned induction, and the patients will be contacted by phone to inform them of their assigned group. The randomization will be stratified by parity and BMI.

Outpatient Foley catheter group:

If the patient was randomized or chose the intervention group (outpatient Foley), she underwent the following. She will present to the Family Birth Center in the evening at 1900. She will undergo a nonstress test (NST), an ultrasound for fetal presentation and amniotic fluid index, and a cervical exam with calculation of a Bishop score. The patient will be asked if she is having regular, painful contractions, decreased fetal movement, vaginal bleeding, leakage of fluid from the vagina concerning for rupture of membranes, or fevers or chills. A Foley catheter will be placed if the following criteria have been met: the nonstress test is reactive and reassuring (without the presence of ≥ 3 variable decelerations in a 20 minute period, late-appearing decelerations, or any deceleration lasting ≥1 minute), the fetal presentation is cephalic, the amniotic fluid index is 5 centimeters or more, the Bishop score is <6, the cervical dilation is <3 cm, and she has no other clinical characteristics that exclude her from the trial as described in the inclusion/exclusion criteria. A 30 French Foley will be placed either digitally or with speculum assistance. It will be inflated with 60 cc of normal saline and taped to the patient's inner thigh. The fetal heart rate tracing will be monitored for 1 hour after Foley placement. The patient will be sent home if the following criteria are met: the fetal heart rate tracing is reactive and category I; there is no evidence of rupture of membranes, spontaneous labor, or vaginal bleeding more than spotting; and no other exclusion criteria are present. Before discharge, the patient may receive pharmacologic pain relief in the form of one dose of acetaminophen and/or fentanyl.

The patient will be instructed to return to the Family Birth Center at 0700 the following day. She will be given detailed verbal and written instructions of when to contact and return to the Family Birth Center before the morning. She will be provided with the 24 hour direct access line for the Family Birth Center to call with any questions or concerns. If the Foley catheter is expulsed at home, she is to record the time of expulsion. She does not need to return to the Family Birth Center earlier than planned due to expulsion.

When the patient returns in the morning, the induction will be continued at the discretion of the providing obstetric team. The remainder of her care during the first, second, and third stages of labor will be at the discretion of the providing team. The patient will have continuous fetal monitoring. All patients' labor progress will be monitored using a partogram. Cesarean delivery will not be performed for arrest of labor or failed induction unless all criteria have been met as outlined by the Family Birth Center Workgroup protocol made effective 6/2/14.

Inpatient usual care group:

If the patient was randomized or chose the control group (inpatient usual care), she will arrive to the Family Birth Center at 1900 to undergo induction of labor. She will undergo a nonstress test (NST), an ultrasound for fetal presentation and amniotic fluid index, and a cervical exam with calculation of a Bishop score. The patient will be asked if she is having regular, painful contractions, decreased fetal movement, vaginal bleeding, leakage of fluid from the vagina concerning for rupture of membranes, or fevers or chills. She will be included or excluded from the study based on the above information. Induction of labor may proceed at the discretion of the providing obstetric team. Cervical ripening should be performed with either 25 mcg vaginal misoprostol every 4 hours with a maximum of six doses or a 30 Fr Foley catheter filled with 60 cc normal saline. The patient may need both methods during her inpatient stay if her cervix is unfavorable. A Foley catheter will be favored during the cervical ripening phase if there is tachysystole and/or a nonreassuring fetal heart tracing precluding further misoprostol administration, provided the Bishop score is still <6. The remainder of her care during the first, second, and third stages of labor will be at the discretion of the providing team. All patients' labor progress will be monitored using a partogram. Cesarean delivery will not be performed for arrest of labor or failed induction unless all criteria have been met as outlined by the Family Birth Center Workgroup protocol made effective 6/2/14.

Follow up

Each mother was asked to complete a survey before leaving the hospital describing her experience and satisfaction with the cervical ripening process (both study designs. Primary and secondary endpoints will be collected from neonatal and maternal charts through 42 days after the patient's delivery or the date of the patient's final postpartum clinic visit, whichever comes last.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 39
• Est. completion date: June 8, 2017
• Est. primary completion date: June 8, 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria

1. Pregnant women at =37 weeks gestation by reliable dating criteria as determined by the American College of Obstetricians and Gynecologists (i.e. gestational age supported by one of the following: ultrasound prior to 20 weeks of gestation, fetal heart tones auscultated by Doppler for 30+ weeks, or documented serum or urine pregnancy test 36+ weeks ago)

2. Scheduled induction of labor with indication and timing supported by the Family Birth Center induction of labor guideline entitled "Induction of labor: Indications and Timing"

3. Singleton gestation

4. Cephalic presentation

5. Amniotic fluid index greater than or equal to 5 centimeters

6. Formal prenatal ultrasound documenting the absence of placenta previa

7. Bishop score <6 and cervical dilation <3cm

8. The woman is able to give appropriate consent and has undergone an informed consent process.

9. Maternal age = 18 years old at the time of consent.

Exclusion Criteria

1. New diagnosis requiring immediate hospitalization for monitoring (such as new onset hypertensive disease of pregnancy)

2. Vaginal bleeding

3. Active labor

4. Premature rupture of membranes as determined by positive ferning and as supported by pooling of fluid in the vaginal vault.

5. Uterine tachysystole (>5 contractions in 10 minutes)

6. Nonreassuring fetal heart tracing before or after Foley placement

7. Chorioamnionitis or maternal fever

8. Intrauterine fetal demise

9. Contraindication to vaginal delivery, relative or absolute (i.e. transfundal uterine surgery)

10. Abnormal placentation including a low lying placenta

11. Prior cesarean delivery

12. Intrauterine growth restriction (growth <10th percentile by formal ultrasound)

13. Known fetal anomaly

14. Human immunodeficiency virus, Hepatitis C, or active herpes infection

15. Maternal cardiopulmonary disease requiring cardiac monitoring during labor

16. Pregestational diabetes

17. Rh isoimmunization

18. Non-English speaking

19. Distance from the hospital over 60 minutes by car, unreliable communication via telephone, or unreliable transportation

Related Conditions & MeSH terms

• Pregnancy

Intervention

Device:
• Foley catheter
The Foley catheter is a device used to achieve cervical ripening at the start of labor induction. It is a single balloon catheter placed transcervically by a provider, either digitally or using a speculum for visualization. The balloon is placed above the internal os but below the fetal head, amniotic membranes, and placenta and is inflated. In this study, it will be inflated with 60 cc of normal saline and taped to the patient's thigh for traction. Over several hours, the balloon gradually dilates the cervix. The catheter is typically expulsed when the cervix is 3-4 centimeters.

Drug:
• Misoprostol
Misoprostol is a prostaglandin E1 analogue that is used for cervical ripening during labor induction. A 25 microgram tablet is placed in the vagina by a provider. A new 25 mcg tablet can be used vaginally every 4 hours for up to 6 total doses.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

References & Publications (3)

Henry A, Madan A, Reid R, Tracy SK, Austin K, Welsh A, Challis D. Outpatient Foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. BMC Pregnancy Childbirth. 2013 Jan 29;13:25. doi: 10.1186/1471-2393-13-25. — View Citation

Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. doi: 10.1002/14651858.CD001233.pub2. Review. — View Citation

Sciscione AC, Muench M, Pollock M, Jenkins TM, Tildon-Burton J, Colmorgen GH. Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001 Nov;98(5 Pt 1):751-6. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pre-delivery Hospitalization Time	The time from when the patient is admitted to the hospital until she delivers her infant and placenta will be recorded. For the outpatient group, this will be measured by adding together the time that the patient spends in the Family Birth Center during Foley placement in the evening with the time she spends inpatient the next day during the rest of her induction until delivery.	Delivery, approximately 16 to 30 hours after admission
Secondary	Mean Score on Maternal Satisfaction Survey	This survey will gauge the mother's experience during her induction with regard to pain, rest, concerns during the induction, satisfaction, and willingness to recommend their particular induction setting (inpatient vs. outpatient). Questions are based on a 1-4 scale, with higher scores indicating greater satisfaction.	Discharge from the hospital, approximately 2-3 days after delivery
Secondary	Number of Participants Per Method of Induction Used	Method of induction: outpatient placement of Foley catheter vs. inpatient usual care induction (medication and/or Foley catheter at time of admission)	End of the third stage of labor, approximately 16 hours after admission
Secondary	Mean Dose of Medication for Pain Relief	Mean dose of opioid pain medication (Fentanyl) in micrograms	End of the third stage of labor, approximately 16 hours after admission
Secondary	Mean Time of Delivery	Time from admission to the hospital to delivery of the placenta.	End of the third stage of labor, approximately 16 to 30 hours after admission
Secondary	Number of Participants With Normal Spontaneous Vaginal Delivery		End of the third stage of labor, approximately 16 hours after admission
Secondary	Mean Estimated Blood Loss at Delivery	Estimated total blood loss at time of delivery in milliliters.	End of the third stage of labor, approximately 16 hours after admission
Secondary	Number of Participants With Intrapartum Complications	Intrapartum complications defined as intrapartum fever, placental abruption, or chorioamnionitis.	Final postpartum visit, approximately 42 days after delivery
Secondary	Number of Participants With Postpartum Complications	Postpartum complications defined as postpartum hemorrhage, depression, urinary tract infection, wound infection, endomyometritis, mastitis, pyelonephritis, intra-abdominal infection, deep vein thrombosis, pulmonary thrombosis, cardiac complication, or fever of unknown origin.	Final postpartum visit, approximately 42 days after delivery
Secondary	Mean Readmission Rate	Defined as readmission to the hospital for any reason within 6 weeks from the date of delivery.	Final postpartum visit, approximately 42 days after delivery
Secondary	Number of Infants Per Gender	Gender defined as male or female.	Neonatal discharge from the hospital, approximately 2-3 days after delivery
Secondary	Mean Birth Weight	Mean infant birth weight reported in grams.	Neonatal discharge from the hospital, approximately 2-3 days after delivery
Secondary	Mean APGAR Scores	APGAR (Appearance, Pulse, Grimace, Activity, Respiration) Scoring System. 1-10 scale with higher total score indicating better newborn health. Infant mean APGAR score at 5 minutes reported.	Neonatal discharge from the hospital, approximately 2-3 days after delivery
Secondary	Mean Umbilical Cord Blood Gases	Mean infant venous pH reported from complete umbilical cord blood gases.	Neonatal discharge from the hospital, approximately 2-3 days after delivery
Secondary	Number of Infants With Neonatal Morbidity or Mortality, Categorized by Reason.	Any diagnosed neonatal morbid condition or mortality prior to hospital discharge.	Neonatal discharge from the hospital, approximately 2-3 days after delivery

External Links

•   Mayo Clinic Clinical Trials